Symbol
Cyclacel Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.23
Current price of the stock
$139K
Trading volume of the stock
$-2.5M
Market capitalization of the company
Nano Cap
Category of market capitalization
-
Long-term growth mean estimate
3.00
Mean analyst rating
334.78%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
0.77
Current ratio
100.00%
Gross profit margin
-21770.00%
Operating profit margin
-21770.00%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-21670.00%
Pretax profit margin
-19570.00%
Net profit margin
201.76%
Measures profitability relative to shareholders' equity
201.75%
ROE excluding intangible assets
-36.37%
Measures profitability relative to total assets
201.75%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.01
Measures valuation relative to earnings
-
P/E based on future earnings estimates
-33.79
Measures valuation relative to sales
-0.51
Measures valuation relative to book value
-0.01
Measures valuation relative to operating cash flow
-0.01
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
